Moyra Mortbyprofile image

Moyra Mortby

Current Appointments

Research Fellow
email hidden; JavaScript is required

Dr Moyra Mortby is a Psychologist specialised in neuropsychiatric symptoms in dementia and pre-clinical stages of dementia and is an NHMRC-ARC Dementia Research Development Fellow. She was awarded her PhD with Laudatio Magna Cum Laude from the University of Zurich, Switzerland for her research on apathy and depression in Mild Cognitive Impairment and Alzheimer’s disease, and completed her MSc in Research Methods in Psychology and BSc in Criminology and Psychology both at Keele University, UK.

Her research program focuses on neuropsychiatric symptoms in dementia and pre-clinical stages of dementia, neuroimaging and epidemiology. 2015 International Society to Advance Alzheimer’s Research and Treatment (ISTAART) and the Neuropsychiatric Syndromes (NPS) in Neurodegenerative diseases Professional Interest Area (PIA) New Investigator Award.

Her research program is structured around 4 key areas which aim to: 1) improve our understanding of dementia, its risk factors and trajectories; 2) better understand the impact of neuropsychiatric symptoms on dementia trajectories, quality of life and the provision of formal and informal care; 3) validate the concept of Mild Behavioural Impairment as a pre-clinical stage of dementia; and 4) develop and evaluate interventions to reduce neuropsychiatric symptoms associated with dementia, improve quality of life for people living with dementia and those providing care and develop useful support mechanisms.


2023, 01 Mar

Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders

View full journal-article on

2023, 01 Mar

Residential aged care staff perceptions and responses towards neuropsychiatric symptoms: a mixed methods analysis of electronic healthcare records

View full journal-article on


Mixed Evidence of an Association between Self-Rated Hearing Difficulties and Falls: Prospective Analysis of Two Longitudinal Studies

View full journal-article on

2022, 01 Dec

Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis

View full journal-article on

2022, 03 Nov

The impact of mild cognitive impairment on decision-making under explicit risk conditions: Evidence from the Personality and Total Health (PATH) Through Life longitudinal study.

View full journal-article on

2022, 01 May

Diastolic Blood Pressure Variability in Later Life May Be a Key Risk Marker for Cognitive Decline

View full journal-article on

2022 Apr

Non-pharmacological interventions for neuropsychiatric symptoms of dementia in residential aged care settings: An umbrella review

View full journal-article on

2022, 20 Mar

Who displays dementia-related stigma and what does the general public know about dementia? Findings from a nationally representative survey

View full journal-article on

2022, 01 Mar

Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials

View full journal-article on

2022, 01 Jan

Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions

View full journal-article on

Donate to us

Every dollar of community support enables our scientists to continue making life-changing discoveries that contribute to a brighter and healthier future.


Fundraise for us

Run, swim or bake your way to making a positive difference in the lives of people touched by brain and nervous system disorders.

Get involved